Divyen Patel

Dr. Divyen Patel is the CEO and Founder of Genome Explorations Inc., the first commercial Genomic services provider approved by Affymetrix, which has provided gene expression, microRNA expression, genotyping, Next Generation Sequencing (NGS) and advanced data analysis services to more than 800 different academic, governmental, and commercial institutions since 2001. Dr. Patel started and managed the Genomics core at St. Jude Children's Research Hospital and produced, among many studies, seminal work on the use of global genomics to enhance diagnosis of pediatric leukemia and evaluate prognostic outcome in patients (highlighted on the cover of Cancer Cell Vol. 1 133-143 March 2002). At Genome Explorations, Dr. Patel has published over a 180 peer-reviewed publications identifying novel molecular signatures that are causative agents for a wide spectrum of diseases. The extensive experience gained through working with scores of investigators on application of molecular technologies to a wide spectrum of diseases, puts Dr. Patel in a unique position to help develop novel diagnostic products eventually precision therapeutic protocols. Dynamic leader with a proven track record in revenue development and entrepreneurial leadership as CEO of Genome Explorations. Successfully established strategic alliances and identified growth opportunities, enhancing organizational productivity. Expert in marketing and policies development, fostering strong relationships within the community and industry.

• Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad spectrum antifolate resistance in murine bone marrow cells., Patel, D.H., Allay, J.A., Belt, J.A. and Sorrentino, B.P., Blood, 95, 2356-2363, 2000
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling., Yeoh, E-J. Ross, M.E. Shurtleff, S.A. Williams, W.K. Patel, D.H. Mahfouz, Behm, F.B. Susana C. Raimondi, S.C. Relling, M.V. Patel, A. Cheng, C. Campana, D. Wilkins, D. Zhou, X. Li, J. Liu, H. Pui, C-H. Evans, W.E. Naeve, C. Wong, L. and Downing J.R., Cancer Cell, 1, 133-143, 2002
• Shaping gene expression in activated and resting primary macrophages by IL-10., Lang, R., Patel, D., Morris, J.J., Rutschman, R.L. and Murray, P.J., J Immunol., 169(5), 2253-2263, 2002
• Alpha 1 adrenergic receptor control of renal blood vessels during aging., Passmore, J.C., Rowell, P.P., Joshua, J.G., Porter, J.P., Patel, D.H. and Falcone, J.C., Can. J. Physiol. Pharmacol., 83, 335-342, 2005
• 
  

• Gujariti, Fluent
• French, Conversational
• German, Conversational
• Hindi, Conversational

190-133-75619